I find it interesting that the company is choosing not to spruik the numbers, nor place a value of the ulcer market. Let the science speak first?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025